Early aggressive lipid-lowering strategy with PCSK9 siRNA performs better than usual care in US patients with ASCVD

Michael Gibson at the ACC24
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free